{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T17:52:04Z","timestamp":1769104324192,"version":"3.49.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"25","license":[{"start":{"date-parts":[[2013,8,5]],"date-time":"2013-08-05T00:00:00Z","timestamp":1375660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2013,8,5]],"date-time":"2013-08-05T00:00:00Z","timestamp":1375660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2014,6,19]]},"DOI":"10.1038\/onc.2013.295","type":"journal-article","created":{"date-parts":[[2013,8,5]],"date-time":"2013-08-05T10:21:47Z","timestamp":1375698107000},"page":"3288-3297","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Deletion of Irf5 protects hematopoietic stem cells from DNA damage-induced apoptosis and suppresses \u03b3-irradiation-induced thymic lymphomagenesis"],"prefix":"10.1038","volume":"33","author":[{"given":"X","family":"Bi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Korczeniewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Alper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B J","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,8,5]]},"reference":[{"key":"BFonc2013295_CR1","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.cell.2008.01.036","volume":"132","author":"DJ Rossi","year":"2008","unstructured":"Rossi DJ, Jamieson CH, Weissman IL . Stem cells and the pathways to aging and cancer. Cell 2008; 132: 681\u2013696.","journal-title":"Cell"},{"key":"BFonc2013295_CR2","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1126\/science.274.5293.1664","volume":"274","author":"SJ Elledge","year":"1996","unstructured":"Elledge SJ . Cell cycle checkpoints: preventing an identity crisis. Science 1996; 274: 1664\u20131672.","journal-title":"Science"},{"key":"BFonc2013295_CR3","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nrm2147","volume":"8","author":"KH Vousden","year":"2007","unstructured":"Vousden KH, Lane DP . P53 in health and disease. Nat Rev Mol Cell Biol 2007; 8: 275\u2013283.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFonc2013295_CR4","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1084\/jem.20061552","volume":"203","author":"M Erlacher","year":"2006","unstructured":"Erlacher M, Labi V, Manzl C, Bock G, Tzankov A, Hacker G et al. Puma cooperates with Bim, the rate-limiting BH3-only protein in cell death during lymphocyte development, in apoptosis induction. J Exp Med 2006; 203: 2939\u20132951.","journal-title":"J Exp Med"},{"key":"BFonc2013295_CR5","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1038\/cdd.2008.16","volume":"15","author":"EM Michalak","year":"2008","unstructured":"Michalak EM, Villunger A, Adam JM, Strasser A . In several cell types the tumour suppressor p53 induces apoptosis largely via Puma but Noxa can contribute. Cell Death Differ 2008; 15: 1019\u20131029.","journal-title":"Cell Death Differ"},{"key":"BFonc2013295_CR6","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/ng0994-66","volume":"8","author":"CJ Kemp","year":"1994","unstructured":"Kemp CJ, Wheldon T, Balmain A . P53-deficient mice are extremely susceptible to radiation-induced tumorigenesis. Nat Genet 1994; 8: 66\u201369.","journal-title":"Nat Genet"},{"key":"BFonc2013295_CR7","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1038\/cdd.2010.43","volume":"17","author":"PN Kelly","year":"2010","unstructured":"Kelly PN, White MJ, Goschnick MW, Fairfax KA, Tarlinton DM, Kinkel SA et al. Individual and overlapping roles of BH3-only proteins Bim and Bad in apoptosis of lymphocytes and platelets and in suppression of thymic lymphoma development. Cell Death Differ 2010; 17: 1655\u20131664.","journal-title":"Cell Death Differ"},{"key":"BFonc2013295_CR8","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1101\/gad.1940110","volume":"24","author":"EM Michalak","year":"2010","unstructured":"Michalak EM, Vandenberg CJ, Delbridge ARD, Wu L, Scott CL, Adams JM et al. Apoptosis-promoted tumorigenesis: \u03b3-irradiation-induced thymic lymphomagenesis requires Puma-driven leukocyte death. Genes Dev 2010; 24: 1608\u20131613.","journal-title":"Genes Dev"},{"key":"BFonc2013295_CR9","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1101\/gad.1940210","volume":"24","author":"V Labi","year":"2010","unstructured":"Labi V, Erlacher M, Krumschnabel G, Manzl C, Tzankov A, Pinon J et al. Apoptosis of leukocytes triggered by acute DNA damage promotes lymphoma formation. Genes Dev 2010; 24: 1602\u20131607.","journal-title":"Genes Dev"},{"key":"BFonc2013295_CR10","doi-asserted-by":"publisher","first-page":"2914","DOI":"10.1038\/sj.onc.1205459","volume":"21","author":"T Mori","year":"2002","unstructured":"Mori T, Anazawa Y, Iiizumi M, Fukuda S, Nakamura Y, Arakawa H . Identification of the interferon regulatory factor 5 gene (IRF-5) as a direct target for p53. Oncogene 2002; 21: 2914\u20132918.","journal-title":"Oncogene"},{"key":"BFonc2013295_CR11","first-page":"6424","volume":"63","author":"BJ Barnes","year":"2003","unstructured":"Barnes BJ, Kellum MJ, Pinder KE, Frisancho JA, Pitha PM . Interferon regulatory factor 5, a novel mediator of cell cycle arrest and cell death. Cancer Res 2003; 63: 6424\u20136431.","journal-title":"Cancer Res"},{"key":"BFonc2013295_CR12","doi-asserted-by":"publisher","first-page":"7403","DOI":"10.1158\/0008-5472.CAN-05-0583","volume":"65","author":"G Hu","year":"2005","unstructured":"Hu G, Mancl ME, Barnes BJ . Signaling through IFN regulatory factor-5 sensitizes p53-deficient tumors to DNA damage-induced apoptosis and cell death. Cancer Res 2005; 65: 7403\u20137412.","journal-title":"Cancer Res"},{"key":"BFonc2013295_CR13","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.1073\/pnas.0611559104","volume":"104","author":"H Yanai","year":"2007","unstructured":"Yanai H, Chen HM, Inuzuka T, Kondo S, Mak TW, Takaoka A et al. Role of IFN regulatory factor 5 transcription factor in antiviral immunity and tumor suppression. Proc Natl Acad Sci USA 2007; 104: 3402\u20133407.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2013295_CR14","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1182\/blood-2003-04-1161","volume":"103","author":"T Stankovic","year":"2004","unstructured":"Stankovic T, Hubank M, Cronin D, Stewart GS, Fletcher D, Bignell CR et al. Microarray analysis reveals that TP53- and ATM-mutant B-CLLs share a defect in activating proapoptotic responses after DNA damage but are distinguished by major differences in activating prosurvival responses. Blood 2004; 103: 291\u2013300.","journal-title":"Blood"},{"key":"BFonc2013295_CR15","doi-asserted-by":"publisher","first-page":"e5500","DOI":"10.1371\/journal.pone.0005500","volume":"4","author":"L Yang","year":"2009","unstructured":"Yang L, Zhao T, Shi X, Nakhaei P, Wang Y, Sun Q et al. Functional analysis of a dominant negative mutation of interferon regulatory factor 5. PLoS One 2009; 4: e5500.","journal-title":"PLoS One"},{"key":"BFonc2013295_CR16","doi-asserted-by":"publisher","first-page":"23382","DOI":"10.1074\/jbc.M101216200","volume":"276","author":"BJ Barnes","year":"2001","unstructured":"Barnes BJ, Moore PA, Pitha PM . Virus-specific activation of a novel interferon regulatory factor, IRF-5, results in the induction of distinct interferon alpha genes. J Biol Chem 2001; 276: 23382\u201323390.","journal-title":"J Biol Chem"},{"key":"BFonc2013295_CR17","doi-asserted-by":"publisher","first-page":"e44997","DOI":"10.1371\/journal.pone.0044997","volume":"7","author":"AJ Watkins","year":"2012","unstructured":"Watkins AJ, Hamoudi RA, Zeng N, Yan Q, Huang Y, Liu H et al. An integrated genomic and expression analysis of 7q deletion in splenic marginal zone lymphoma. PLoS One 2012; 7: e44997.","journal-title":"PLoS One"},{"key":"BFonc2013295_CR18","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1111\/j.1365-2141.2012.09226.x","volume":"158","author":"V Fresquet","year":"2012","unstructured":"Fresquet V, Robles EF, Parker A, Martinez-Useros J, Mena M, Malumbres R et al. High-throughput sequencing analysis of the chromosome 7q32 deletion reveals IRF5 as a potential tumor supressor in splenic marginal-zone lymphoma. Br J Haematol 2012; 158: 712\u2013726.","journal-title":"Br J Haematol"},{"key":"BFonc2013295_CR19","first-page":"185","volume":"13","author":"HS Kaplan","year":"1952","unstructured":"Kaplan HS, Brown MB . A quantitative dose\u2013response study of lymphoid-tumor development in irradiated C57 black mice. J Natl Cancer Inst 1952; 13: 185\u2013208.","journal-title":"J Natl Cancer Inst"},{"key":"BFonc2013295_CR20","first-page":"207","volume":"14","author":"HS Kaplan","year":"1964","unstructured":"Kaplan HS . The role of irradiation on experimental leukemogenesis. Natl Cancer Inst Monogr 1964; 14: 207\u2013220.","journal-title":"Natl Cancer Inst Monogr"},{"key":"BFonc2013295_CR21","doi-asserted-by":"publisher","first-page":"3741","DOI":"10.4049\/jimmunol.1201162","volume":"189","author":"L Yang","year":"2012","unstructured":"Yang L, Feng D, Bi X, Stone RC, Barnes BJ . Monocytes from Irf5\u2212\/\u2212mice have an intrinsic defect in their response to pristane-induced lupus. J Immunol 2012; 189: 3741\u20133750.","journal-title":"J Immunol"},{"key":"BFonc2013295_CR22","doi-asserted-by":"publisher","first-page":"e11439","DOI":"10.1371\/journal.pone.0011439","volume":"5","author":"HJ Kim","year":"2010","unstructured":"Kim HJ, Alonzo ES, Dorothee G, Pollard JW, Snat-Angelo DB . Selective depletion of eosinophils or neutrophils in mice impacts the efficiency of apoptotic cell clearance in the thymus. PLoS One 2010; 5: e11439.","journal-title":"PLoS One"},{"key":"BFonc2013295_CR23","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/j.1349-7006.2006.00218.x","volume":"97","author":"R Kominami","year":"2006","unstructured":"Kominami R, Niwa O . Radiation carcinogenesis in mouse thymic lymphomas. Cancer Sci 2006; 97: 575\u2013581.","journal-title":"Cancer Sci"},{"key":"BFonc2013295_CR24","doi-asserted-by":"publisher","first-page":"R111","DOI":"10.1186\/bcr3053","volume":"13","author":"X Bi","year":"2011","unstructured":"Bi X, Hameed M, Mirani N, Pimenta EM, Anari J, Barnes BJ . Loss of interferon regulatory factor 5 (IRF5) expression in human ductal carcinoma correlates with disease stage and contributes to metastasis. Breast Cancer Res 2011; 13: R111.","journal-title":"Breast Cancer Res"},{"key":"BFonc2013295_CR25","doi-asserted-by":"publisher","first-page":"18261","DOI":"10.1074\/jbc.M110.210542","volume":"286","author":"D Xu","year":"2011","unstructured":"Xu D, Meyer F, Ehlers E, Balsnitz L, Zhang L . Interferon regulatory factor 4 (IRF-4) targets IRF-5 to regulate Epstein\u2013Barr virus transformation. J Biol Chem 2011; 286: 18261\u201318267.","journal-title":"J Biol Chem"},{"key":"BFonc2013295_CR26","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1074\/jbc.M804744200","volume":"284","author":"G Hu","year":"2009","unstructured":"Hu G, Barnes BJ . IRF-5 is a mediator of the death receptor-induced apoptotic signaling pathway. J Biol Chem 2009; 284: 2767\u20132777.","journal-title":"J Biol Chem"},{"key":"BFonc2013295_CR27","doi-asserted-by":"publisher","first-page":"4237","DOI":"10.4161\/cc.10.24.18383","volume":"10","author":"K Botcheva","year":"2011","unstructured":"Botcheva K, McCorkle SR, McCombie WR, Dunn JJ, Anderson CW . Distinct p53 genomic binding patterns in normal and cancer-derived cell lines. Cell Cycle 2011; 10: 4237\u20134249.","journal-title":"Cell Cycle"},{"key":"BFonc2013295_CR28","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1038\/cdd.2012.89","volume":"19","author":"F Nikulenkov","year":"2012","unstructured":"Nikulenkov F, Spinnler C, Li H, Tonnelli C, Shi Y, Turunen M et al. Insights into p53 transcriptional function via genome-wide chromatin occupancy and gene expression analysis. Cell Death Differ 2012; 19: 1992\u20132002.","journal-title":"Cell Death Differ"},{"key":"BFonc2013295_CR29","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.cell.2005.09.029","volume":"123","author":"WS Wu","year":"2005","unstructured":"Wu WS, Heinrichs S, Xu D, Garrison SP, Zambetti GP, Adams JM et al. Slug antagonizes p53-mediated apoptosis of hematopoietic progenitors by repressing puma. Cell 2005; 123: 641\u2013653.","journal-title":"Cell"},{"key":"BFonc2013295_CR30","doi-asserted-by":"publisher","first-page":"3472","DOI":"10.1182\/blood-2009-10-248278","volume":"115","author":"H Yu","year":"2010","unstructured":"Yu H, Shen H, Yuan Y, XuFeng R, Hu X, Garrison SP et al. Deletion of Puma protects hematopoietic stem cells and confers long-term survival in response to high-dose \u03b3-irradiation. Blood 2010; 115: 3472\u20133480.","journal-title":"Blood"},{"key":"BFonc2013295_CR31","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/0360-3016(94)00430-S","volume":"31","author":"P Mauch","year":"1995","unstructured":"Mauch P, Constine L, Greenberger J, Knospe W, Sullivan J, Liesveld JL et al. Hematopoietic stem cell compartment: acute and late effects of radiation therapy and chemotherapy. Int J Radiat Oncol Biol Phys 1995; 31: 1319\u20131339.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BFonc2013295_CR32","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1182\/blood-2005-04-1418","volume":"107","author":"Y Wang","year":"2006","unstructured":"Wang Y, Schulte BA, LaRue AC, Ogawa M, Zhou D . Total body irradiation selectively induces murine hematopoietic stem cell senescence. Blood 2006; 107: 358\u2013366.","journal-title":"Blood"},{"key":"BFonc2013295_CR33","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/nature03308","volume":"434","author":"A Takaoka","year":"2005","unstructured":"Takaoka A, Yanai H, Kondo S, Duncan G, Negishi H, Mitzutani T et al. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 2005; 434: 243\u2013249.","journal-title":"Nature"},{"key":"BFonc2013295_CR34","doi-asserted-by":"publisher","first-page":"17005","DOI":"10.1074\/jbc.M412584200","volume":"280","author":"A Schoenemeyer","year":"2005","unstructured":"Schoenemeyer A, Barnes BJ, Mancl ME, Latz E, Goutagny N, Pitha PM et al. The interferon regulatory factor, IRF5, is a central mediator of toll-like receptor signaling. J Biol Chem 2005; 280: 17005\u201317012.","journal-title":"J Biol Chem"},{"key":"BFonc2013295_CR35","doi-asserted-by":"publisher","first-page":"6003","DOI":"10.4049\/jimmunol.1000482","volume":"185","author":"D Feng","year":"2010","unstructured":"Feng D, Sangster-Guity N, Stone R, Korczeniewska J, Mancl ME, Fitzgerald-Bocarsly P et al. Differential requirement of histone acetylase and deacetylase activities for IRF5-mediated proinflammatory cytokine expression. J Immunol 2010; 185: 6003\u20136012.","journal-title":"J Immunol"},{"key":"BFonc2013295_CR36","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1002\/eji.201141642","volume":"42","author":"D Feng","year":"2012","unstructured":"Feng D, Yang L, Bi X, Stone RC, Patel P, Barnes BJ . Irf5-deficient mice are protected from pristane-induced lupus via increased Th2 cytokines and altered IgG class switching. Europ J Immunol 2012; 42: 1477\u20131487.","journal-title":"Europ J Immunol"},{"key":"BFonc2013295_CR37","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1038\/leu.2011.113","volume":"25","author":"C Liu","year":"2011","unstructured":"Liu C, Gao F, Li B, Mitchel REJ, Liu X, Lin J et al. TLR4 knockout protects mice from radiation-induced thymic lymphoma by downregulation of IL6 and miR-21. Leukemia 2011; 25: 1516\u20131519.","journal-title":"Leukemia"},{"key":"BFonc2013295_CR38","doi-asserted-by":"publisher","first-page":"5391","DOI":"10.1128\/MCB.00907-07","volume":"28","author":"SP Garrison","year":"2008","unstructured":"Garrison SP, Jeffers JR, Yang C, Nilsson JA, Hall MA, Rehg JE et al. Selection against PUMA gene expression in Myc-driven B-cell lymphomagenesis. Mol Cell Biol 2008; 28: 5391\u20135402.","journal-title":"Mol Cell Biol"},{"key":"BFonc2013295_CR39","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/cdd.2008.195","volume":"16","author":"EM Michalak","year":"2009","unstructured":"Michalak EM, Jansen ES, Happo L, Cragg MS, Tai L, Smyth GK et al. Puma and to a lesser extent Noxa are suppressors of Myc-induced lymphomagenesis. Cell Death Differ 2009; 16: 684\u2013696.","journal-title":"Cell Death Differ"},{"key":"BFonc2013295_CR40","doi-asserted-by":"publisher","first-page":"E898","DOI":"10.1073\/pnas.1118155109","volume":"109","author":"WE Purtha","year":"2012","unstructured":"Purtha WE, Swiecki M, Colonna M, Diamond MS, Bhattacharya D . Spontaneous mutation of the Dock2 gene in Irf5\u2013\/\u2013 mice complicates interpretation of type I interferon production and antibody responses. Proc Natl Acad Sci USA 2012; 109: E898\u2013E904.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2013295.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2013295","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2013295.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T19:28:24Z","timestamp":1647890904000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2013295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,5]]},"references-count":40,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2014,6,19]]}},"alternative-id":["BFonc2013295"],"URL":"https:\/\/doi.org\/10.1038\/onc.2013.295","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,5]]},"assertion":[{"value":"16 January 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2013","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2013","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2013","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}